Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

OTSUKA AMERICA PHARMACEUTICAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

POCone-UBiT-IR300 Pediatric Comparison Study

Phase 4

Completed

Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

First Posted Date: 2012-06-19

Last Posted Date: 2015-02-23

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 99

Registration Number: NCT01623154

Locations: 🇺🇸
Miami Pediatric Gastroenterology, Miami, Florida, United States
🇺🇸
University of Texas School of Public Health, El Paso, Texas, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

Completed

Conditions: Euvolemic Hyponatremia
Hypervolemic Hyponatremia

First Posted Date: 2010-11-15

Last Posted Date: 2015-05-15

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 5028

Registration Number: NCT01240668

Locations: 🇺🇸
North America Research Institute, Azusa, California, United States
🇺🇸
Chrishard Medical Group, Inglewood, California, United States
🇺🇸
UCLA, Los Angeles, California, United States

and more 76 locations

Study for the Treatment of Crohn's Disease With Adacolumn

Phase 3

Completed

Conditions: Crohn's Disease

First Posted Date: 2005-09-13

Last Posted Date: 2009-04-07

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 235

Registration Number: NCT00162942

Locations: 🇺🇸
Mayo Clinic Scottsdale, Phoenix, Arizona, United States
🇺🇸
Capitol Gastroenterology Consultants Medical Group, Roseville, California, United States
🇺🇸
UCSF Mount Zion Medical Center, San Francisco, California, United States

and more 33 locations

Study for the Treatment of Ulcerative Colitis With Adacolumn

Phase 3

Completed

Conditions: Ulcerative Colitis

First Posted Date: 2005-01-25

Last Posted Date: 2008-09-08

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 168

Registration Number: NCT00102193

Locations: 🇺🇸
Mayo Clinic Scottsdale, Phoenix, Arizona, United States
🇺🇸
Providence Clinical Research, Burbank, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 34 locations

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Phase 4

Completed

Conditions: Raynaud's Disease

First Posted Date: 2002-11-11

Last Posted Date: 2005-07-19

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 75

Registration Number: NCT00048763

Locations: 🇺🇸
Advanced Medical Clinical Therapeutics, Anchorage, Alaska, United States
🇺🇸
Advanced Medical Research Institute, Fresno, California, United States
🇺🇸
Madera Family Medical Group, Madera, California, United States

and more 15 locations

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Phase 4

Completed

Conditions: Raynaud's Disease

First Posted Date: 2002-11-11

Last Posted Date: 2005-07-19

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 75

Registration Number: NCT00048776

Locations: 🇺🇸
Advanced Medical Clinical Therapeutics, Anchorage, Alaska, United States
🇺🇸
Advanced Medical Research Institute, Fresno, California, United States
🇺🇸
Madera Family Medical Group, Madera, California, United States

and more 16 locations

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

Phase 2

Completed

Conditions: Sarcoma, Kaposi
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 28

Registration Number: NCT00002131

Locations: 🇺🇸
UCLA School of Medicine, Los Angeles, California, United States
🇺🇸
Northwestern Univ Med School, Chicago, Illinois, United States

A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Otsuka America Pharmaceutical

Registration Number: NCT00002130

Locations: 🇺🇸
UCLA School of Medicine, Los Angeles, California, United States
🇺🇸
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States

A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 36

Registration Number: NCT00002129

Locations: 🇺🇸
UCLA School of Medicine, Los Angeles, California, United States

A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Otsuka America Pharmaceutical

Target Recruit Count: 56

Registration Number: NCT00002337

Locations: 🇺🇸
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy